Johnson & Johnson (JNJ): Are Its Medical Device Deals Paying Off?

Johnson & Johnson (NYSE:JNJ) is turning acquired heart technologies into growing sales. Adoption of treatments for hardened arteries supports that strategy, while competition and development spending raise the cost of maintaining its lead. A larger hospital network creates opportunities, but shareholders need ownership to deliver more than a bigger revenue base. Johnson & Johnson (NYSE:JNJ) […]